Finally, the study has a smaller
sample size than originally planned, partly because of slow
enrollment. Slow enrollment has been a hallmark of most
comparative effectiveness clinical trials, in which recruitment
is typically hampered by clinician bias in favor of 1 treatment
strategy or a reimbursement bias that is not comparable
across the tested interventions.